NMPA Approval

Brimonidine Tartrate and Timolol Maleate Eye Drops

Approval Number

国药准字H20223688

Company江西科伦药业有限公司

Registration Date

September 20, 2022

Drug Information

Generic Name

溴莫尼定噻吗洛尔滴眼液

Dosage Form

滴眼剂

Strength

5ml：酒石酸溴莫尼定10.0mg和马来酸噻吗洛尔25.0mg（以噻吗洛尔计）

Drug Type

化学药品

Registration Date

September 20, 2022

Company Information

Applicant Company

Company Name江西科伦药业有限公司

Company Address

江西省抚州市东乡区东红大道516号

Manufacturing Company

Company Name江西科伦药业有限公司

Company Address

江西省抚州市东乡区东红大道516号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

溴莫尼定噻吗洛尔滴眼液 - NMPA 批准文号 | MedPath